Discovery Labs Reports Fourth Quarter 2009 Financial Results and Provides Business Update
10 mars 2010 07h45 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., March 10, 2010 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today announces financial results for the fourth quarter ended December 31, 2009 and provides a business...
Discovery Labs Announces Completion of $16.5 Million Public Offering
23 févr. 2010 10h45 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., Feb. 23, 2010 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today announced that it has completed its previously announced public offering to sell an aggregate of...
Discovery Labs Prices $16.5 Million Public Offering of Common Stock and Warrants
18 févr. 2010 08h45 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., Feb. 18, 2010 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today announced that it has priced an underwritten public offering of 27,500,000 units at a price to the...
Discovery Labs Announces Proposed Public Offering of Common Stock and Warrants
17 févr. 2010 16h05 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., Feb. 17, 2010 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today announced that it intends to offer, subject to market and other conditions, shares of its common...
Discovery Labs Receives FDA Guidance Regarding Pathway to Potential SURFAXIN(R) Approval
16 févr. 2010 07h15 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., Feb. 16, 2010 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) announced today that, in response to written guidance recently received from the U.S. Food and Drug...
POPG, a Key Component of Discovery Labs' KL4 Surfactant, Identified as a Novel Anti-Viral Therapeutic Approach
19 janv. 2010 07h30 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., Jan. 19, 2010 (GLOBE NEWSWIRE) -- Research recently published in the Proceedings of the National Academy of Sciences indicates that a naturally occurring phospholipid in pulmonary...
Discovery Labs Receives Nasdaq Notification Related to Minimum Bid Price
04 déc. 2009 16h15 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., Dec. 4, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) announced today that, on December 2, 2009, the Company received a letter from The Nasdaq Stock Market...
Discovery Labs Submits SURFAXIN Pharmacodynamic Trial Protocol to FDA
17 nov. 2009 07h00 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., Nov. 17, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) announced today that it has submitted to the U.S. Food and Drug Administration (FDA) its proposed protocol...
Discovery Labs to Present at the Lazard Capital Markets Healthcare Conference
10 nov. 2009 16h15 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., Nov. 10, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) announced today that Thomas F. Miller, Ph.D., Senior Vice President of Corporate Development of Discovery...
Discovery Labs' Third Quarter 2009 Financial Update
04 nov. 2009 08h15 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., Nov. 4, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) is providing financial results for the third quarter ended September 30, 2009. The Company will host a...